Drug Utilization Review Board
Meeting Agenda
Thursday, June 12, 2025
7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#
Persons who wish to address the DUR Board may contact Luis Moreno at
lmoreno@utah.gov prior to the meeting, or sign up to provide comments at the
meeting. Public comments will be limited to 3 minutes per speaker or organization
due to time constraints.
1) Call to order - Sharon Weinstein, MD
a) Welcome and Introductions
b) Review and Approval of Minutes
2) P&T Committee Update - Ngan Huynh, PharmD
3) Annual Open Public Meeting Training - Tony Patterson, Assistant Attorney
General
4) Review
a) Tryvio (aprocitentan) DRRC Presentation - Monet Luloh, PharmD
i) Committee Discussion/Questions
b) Public Comment
c) Tryvio (aprocitentan) Prior Authorization - Iris Wan, PharmD
i) Committee Discussion/Questions
ii) Committee Action
d) Zynteglo (betibeglogene autotemcel) Prior Authorization..............Ngan Huynh, PharmD
i) Committee Discussion/Questions
ii) Committee Action
e) GLP-1 Medications for Weight Loss Prior Authorization................Kyu Yun Park, PharmD
i) Committee Discussion/Questions
ii) Committee Action
5) Next Meeting
a) July 10, 2025 - Cobenfy (xanomeline & trospium chloride) Report & prior authorization review, and review prior authorization forms: Adzynma,
Cablivi, and Kebildi.
6) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306#